Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01862497 · ClinicalTrials.gov registry record
Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 76
- Enrollment target
NCT01862497: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT01862497 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01862497 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is 1) to determine what physiologic factors (extracellular fluid overload or vasoconstriction) contribute more to increased blood pressure levels between dialysis treatments in hemodialysis patients whose blood pressure increases and decreases during hemodialysis and 2) to determine whether carvedilol provides better control of blood pressure between dialysis treatments than prazosin in patients whose blood pressure increases during dialysis.
Interventions
- DRUG Carvedilol vs. Prazosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-04 |
What the finished NCT01862497 record still lists
NCT01862497 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Carvedilol vs. Prazosin is the first listed.
NCT01862497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01862497 about?
NCT01862497 is a clinical study titled "Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension". The purpose of this study is 1) to determine what physiologic factors (extracellular fluid overload or vasoconstriction) contribute more to increased blood pressure levels between dialysis treatments in hemodialysis patients whose blood pressure increases and decreases during hemodialysis and 2) to ...
What is the current status of trial NCT01862497?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2013-01. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01862497?
The interventions under investigation include: Carvedilol vs. Prazosin (DRUG).
Who is sponsoring clinical trial NCT01862497?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia